Literature DB >> 26124004

The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.

Zhuo Zhang1, Xue-Feng Yang2, Ke-Qiang Huang3, Li Ren3, Wen-Feng Gou2, Dao-Fu Shen2, Shuang Zhao2, Hong-Zhi Sun2, Yasuo Takano4, Hua-Chuan Zheng5.   

Abstract

Downregulated parafibromin expression is involved in the pathogenesis and progression of parathyroid, breast, gastric, colorectal, and lung cancers. To investigate the roles of parafibromin expression in tumorigenesis, progression, and prognostic evaluation of head and neck squamous cell carcinomas (HNSCCs), we transfected parafibromin-expressing plasmid into HNSCC cell and examined the phenotypes and their relevant molecules. Parafibromin expression was detected on tissue microarray containing squamous epithelium, dysplasia, and carcinoma of head and neck by immunohistochemistry. Parafibromin overexpression was found to suppress growth, migration, and invasion, and induce apoptosis, S arrest, and mesenchymal to epithelial transition (EMT), compared with the mock and control (P < 0.05). Both overexpression of Cyclin E1, Bax, and E-cadherin and hypoexpression of c-myc, Bcl-xL, and slug were detected in B88 transfectants, in comparison to mock and control by real-time PCR. Parafibromin expression was weaker in primary cancers than those in normal squamous tissue and dysplasia (P < 0.05), but stronger than the metastatic cancers in lymph node (P < 0.05). Parafibromin expression was negatively correlated with lymph node metastasis, tumor-node-metastasis (TNM) staging, but positively with human papillomavirus (HPV) positivity (P < 0.05). The HNSCCs in tongue showed more parafibromin expression than those in larynx (P < 0.05). There was stronger parafibromin expression in moderately-than poorly-differentiated carcinomas (P < 0.05). The significantly positive correlation was observed between parafibromin expression and relapse-free survival rate by Kaplan-Meier curves (P < 0.05). Cox's proportional hazard model indicated that distant metastasis and parafibromin expression were independent prognostic factors for overall and relapse-free survival of HNSCC, respectively (P < 0.05). These findings suggest that downregulated expression of parafibromin protein plays an important role in the pathogenesis, differentiation, and metastasis of HNSCCs possibly by inducing apoptosis, suppressing proliferation, cell cycle progression, migration, invasion, and EMT. Parafibromin expression is an independent factor for relapse-free survival of HNSCCs.

Entities:  

Keywords:  Head and neck squamous cell carcinoma; Parafibromin; Pathogenesis; Prognosis; Progression

Mesh:

Substances:

Year:  2015        PMID: 26124004     DOI: 10.1007/s13277-015-3618-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital.

Authors:  Tokimasa Kumada; Koichi Tsuneyama; Hideki Hatta; Shin Ishizawa; Yasuo Takano
Journal:  Mod Pathol       Date:  2004-09       Impact factor: 7.842

Review 2.  Mitochondrial alterations in apoptosis.

Authors:  Katia Cosentino; Ana J García-Sáez
Journal:  Chem Phys Lipids       Date:  2014-04-13       Impact factor: 3.329

3.  The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.

Authors:  Armelle Yart; Matthias Gstaiger; Christiane Wirbelauer; Maria Pecnik; Dimitrios Anastasiou; Daniel Hess; Wilhelm Krek
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen.

Authors:  T Iwata; N Mizusawa; Y Taketani; M Itakura; K Yoshimoto
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

Review 5.  The cell cycle and cancer.

Authors:  Gareth H Williams; Kai Stoeber
Journal:  J Pathol       Date:  2011-10-28       Impact factor: 7.996

6.  Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.

Authors:  Ling Lin; Meggan Czapiga; Lylia Nini; Jian-Hua Zhang; William F Simonds
Journal:  Mol Cancer Res       Date:  2007-02       Impact factor: 5.852

7.  Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.

Authors:  Huachuan Zheng; Hiroyuki Takahashi; Yoshihiro Murai; Zhengguo Cui; Kazuhiro Nomoto; Hideki Niwa; Koichi Tsuneyama; Yasuo Takano
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

8.  The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.

Authors:  Ling Lin; Jian-Hua Zhang; Leelamma M Panicker; William F Simonds
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

9.  Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.

Authors:  Min-Han Tan; Chin Fong Wong; Hwei Ling Tan; Ximing J Yang; Jonathon Ditlev; Daisuke Matsuda; Sok Kean Khoo; Jun Sugimura; Tomoaki Fujioka; Kyle A Furge; Eric Kort; Sophie Giraud; Sophie Ferlicot; Philippe Vielh; Delphine Amsellem-Ouazana; Bernard Debré; Thierry Flam; Nicolas Thiounn; Marc Zerbib; Gérard Benoît; Stéphane Droupy; Vincent Molinié; Annick Vieillefond; Puay Hoon Tan; Stéphane Richard; Bin Tean Teh
Journal:  BMC Cancer       Date:  2010-05-12       Impact factor: 4.430

10.  CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.

Authors:  Filomena Cetani; Chiara Banti; Elena Pardi; Simona Borsari; Paolo Viacava; Paolo Miccoli; Liborio Torregrossa; Fulvio Basolo; Maria Rosa Pelizzo; Massimo Rugge; Gianmaria Pennelli; Guido Gasparri; Mauro Papotti; Marco Volante; Edda Vignali; Federica Saponaro; Claudio Marcocci
Journal:  Endocr Connect       Date:  2013-10-28       Impact factor: 3.335

View more
  8 in total

1.  Parafibromin governs cell polarity and centrosome assembly in Drosophila neural stem cells.

Authors:  Qiannan Deng; Cheng Wang; Chwee Tat Koe; Jan Peter Heinen; Ye Sing Tan; Song Li; Cayetano Gonzalez; Wing-Kin Sung; Hongyan Wang
Journal:  PLoS Biol       Date:  2022-10-12       Impact factor: 9.593

2.  Distinct roles of parafibromin in the extracellular environment, cytoplasm and nucleus of osteosarcoma cells.

Authors:  Jia-Jun Zhu; Yan Cui; Kai Cui; Xi Li; Zhi-Yu Zhang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

3.  The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.

Authors:  Dao-Fu Shen; Xin Liu; Xue-Feng Yang; Lei Fang; Yang Gao; Shuang Zhao; Ji-Cheng Wu; Shuai Shi; Jun-Jun Li; Xiang-Xuan Zhao; Wen-Feng Gou; Hua-Chuan Zheng
Journal:  Tumour Biol       Date:  2015-09-26

4.  The clinicopathological and prognostic significances of CDC73 expression in cancers: a bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Bao-Cheng Gong; Shuang Zhao
Journal:  Oncotarget       Date:  2017-08-24

5.  The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.

Authors:  Hua-Chuan Zheng; Jia-Jie Liu; Jing Li; Ji-Cheng Wu; Lei Yang; Gui-Feng Zhao; Xin Zhao; Hua-Mao Jiang; Ke-Qiang Huang; Zhi-Jie Li
Journal:  Oncotarget       Date:  2017-04-04

Review 6.  The roles of the tumor suppressor parafibromin in cancer.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang
Journal:  Front Cell Dev Biol       Date:  2022-09-21

7.  Significance of Parafibromin Expression in Laryngeal Squamous Cell Carcinomas.

Authors:  Inju Cho; Mija Lee; Sharon Lim; Ran Hong
Journal:  J Pathol Transl Med       Date:  2016-06-23

8.  MAPK/FoxA2-mediated cigarette smoke-induced squamous metaplasia of bronchial epithelial cells.

Authors:  Chunling Du; Jinchang Lu; Lei Zhou; Bo Wu; Feng Zhou; Liang Gu; Donghui Xu; Yingxin Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-11-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.